Ameriprise Financial Inc Karuna Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$161.01 - $317.85 $1.3 Million - $2.56 Million
8,068 Added 23.62%
42,221 $13.4 Million
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $5.23 Million - $6.93 Million
31,787 Added 1343.49%
34,153 $5.77 Million
Q2 2023

Aug 14, 2023
BUY
$176.32 - $240.22 $45,666 - $62,216
259 Added 12.29%
2,366 $513,000
Q1 2023

May 15, 2023
BUY
$161.33 - $204.36 $12,745 - $16,144
79 Added 3.9%
2,107 $382,000
Q4 2022

Feb 14, 2023
SELL
$191.53 - $236.82 $12,449 - $15,393
-65 Reduced 3.11%
2,028 $398,000
Q3 2022

Nov 14, 2022
SELL
$123.79 - $277.42 $20,177 - $45,219
-163 Reduced 7.23%
2,093 $471,000
Q2 2022

Aug 15, 2022
BUY
$93.97 - $143.33 $62,677 - $95,601
667 Added 41.98%
2,256 $285,000
Q1 2022

May 16, 2022
SELL
$98.9 - $132.37 $73,581 - $98,483
-744 Reduced 31.89%
1,589 $201,000
Q4 2021

Feb 14, 2022
SELL
$110.64 - $159.4 $774 - $1,115
-7 Reduced 0.3%
2,333 $306,000
Q3 2021

Nov 15, 2021
BUY
$101.2 - $125.87 $2,631 - $3,272
26 Added 1.12%
2,340 $286,000
Q2 2021

Aug 16, 2021
BUY
$107.45 - $135.95 $19,126 - $24,199
178 Added 8.33%
2,314 $264,000
Q1 2021

May 17, 2021
BUY
$95.46 - $133.08 $3,722 - $5,190
39 Added 1.86%
2,136 $257,000
Q4 2020

Feb 12, 2021
BUY
$75.23 - $109.23 $157,757 - $229,055
2,097 New
2,097 $213,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email